Philips iFR Study Confirms Safety in Diagnosis, Treatment of Heart Disease

A study of 42,000 patients undergoing assessment of coronary blockages confirmed that instantaneous wave-free radio (iFR) is as safe as fractional flow reserve (FFR) while providing a more comfortable, cost-effective and faster diagnosis.

iFR, a pressure-derived index offered only by Philips, avoids the use of hyperemic agents, a class of drugs that maximize blood flow but have a significant impact on the patient experience.

A longitudinal analysis from the National Swedeheart Quality Registry using real world evidence showed no difference between iFR and FFR in major adverse cardiac events.

Read the company’s announcement here.

To read the whole story, click here to subscribe.

Related Topics